Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 2 (2005), Issue 10 (October)

1. Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial.
   Lancet, 366(9492): 1189-96. [Abstract] [Full-text]
2. Estimating the risk of malignant transformation of a choroidal nevus.
   Ophthalmology, 112(10): 1784-9. [Abstract] [Full-text]
3. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study.
   Ophthalmology, 112(10): 1777-83. [Abstract] [Full-text]
4. Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth.
   J Cell Physiol, 205(3): 414-21. [Abstract] [Full-text]
5. Negative regulation of melanogenesis by phospholipase D1 through mTOR/p70 S6 kinase 1 signaling in mouse B16 melanoma cells.
   J Cell Physiol, 205(3): 444-51. [Abstract] [Full-text]
6. Clinicopathological features of and risk factors for multiple primary melanomas.
   JAMA, 294(13): 1647-54. [Abstract] [Full-text]
7. 518A2 melanoma cells are protected by G3139 and other antineoplastic agents against the cytotoxic effects of DTIC.
   Oligonucleotides, 15(3): 206-14. [Abstract] [Full-text]
8. CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype.
   Cancer Immunol Immunother, 54(12): 1162-71. [Abstract] [Full-text]
9. Reduced melanoma-related mortality in uveal melanoma by preenucleation radiotherapy.
   Arch Ophthalmol, 123(10): 1363-7. [Abstract] [Full-text]
10. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
    Cancer Gene Ther, 12(11): 864-72. [Abstract] [Full-text]
11. Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas.
    Am J Ophthalmol, 140(4): 748-9. [Abstract] [Full-text]
12. Population-based incidence of uveal melanoma in various races and ethnic groups.
    Am J Ophthalmol, 140(4): 612-7. [Abstract] [Full-text]
13. Inhibition of melanoma growth by hemocyanin occurs via early apoptotic pathways.
    Am J Surg, 190(5): 713-6. [Abstract] [Full-text]
14. Ircinin-1 induces cell cycle arrest and apoptosis in SK-MEL-2 human melanoma cells.
    Mol Carcinog, 44(3): 162-73. [Abstract] [Full-text]
15. Clinical significance of CXCR3 and CXCR4 expression in primary melanoma.
    Int J Cancer, 117(5): 861-5. [Abstract] [Full-text]
16. Activating mutations in the extracellular domain of the melanoma inducing receptor Xmrk are tumorigenic in vivo.
    Int J Cancer, 117(5): 723-9. [Abstract] [Full-text]
17. Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma.
    Int J Cancer, 117(5): 825-30. [Abstract] [Full-text]
18. High constant incidence rates of second cutaneous melanomas.
    Int J Cancer, 117(5): 877-9. [Abstract] [Full-text]
19. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
    J Natl Cancer Inst, 97(20): 1507-15. [Abstract] [Full-text]
20. Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2.
    Blood, 106(9): 3160-5. [Abstract] [Full-text]
21. Shear stress and shear rate differentially affect the multi-step process of leukocyte-facilitated melanoma adhesion.
    Exp Cell Res, 310(2): 282-92. [Abstract] [Full-text]
22. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
    Carcinogenesis, 26(11): 1856-67. [Abstract] [Full-text]
23. Increased incidence of melanoma in renal transplantation recipients.
    Cancer, 104(9): 1962-7. [Abstract] [Full-text]
24. Ovarian malignant melanoma: unusual presentation of a solitary metastasis.
    Gynecol Oncol, 99(2): 412-4. [Abstract] [Full-text]
25. Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine.
    Int J Cancer, 117(6): 1032-8. [Abstract] [Full-text]
26. Variates of survival in metastatic uveal melanoma.
    J Clin Oncol, 23(31): 8076-80. [Abstract] [Full-text]
27. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
    J Clin Oncol, 23(31): 8065-75. [Abstract] [Full-text]
28. Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.
    J Clin Oncol, 23(31): 8057-64. [Abstract] [Full-text]
29. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
    J Clin Oncol, 23(31): 8048-56. [Abstract] [Full-text]
30. Lymphatic mapping in management of patients with primary cutaneous melanoma.
    Lancet Oncol, 6(11): 877-85. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.